Estimates for quality of life loss due to Respiratory Syncytial Virus.
dc.contributor.author | Hodgson, David | |
dc.contributor.author | Atkins, Katherine E | |
dc.contributor.author | Baguelin, Marc | |
dc.contributor.author | Panovska-Griffiths, Jasmina | |
dc.contributor.author | Thorrington, Dominic | |
dc.contributor.author | van Hoek, Albert Jan | |
dc.contributor.author | Zhao, Hongxin | |
dc.contributor.author | Fragaszy, Ellen | |
dc.contributor.author | Hayward, Andrew C | |
dc.contributor.author | Pebody, Richard | |
dc.date.accessioned | 2019-11-03T16:42:32Z | |
dc.date.available | 2019-11-03T16:42:32Z | |
dc.date.issued | 2019-10-18 | |
dc.identifier.issn | 1750-2659 | |
dc.identifier.pmid | 31625688 | |
dc.identifier.doi | 10.1111/irv.12686 | |
dc.identifier.uri | http://hdl.handle.net/10029/623455 | |
dc.description.abstract | For confirmed RSV cases in children under 5 years of age who sought health care, our model predicted a QALY loss per RSV episode of 3.823 × 10-3 (95% CI 0.492-12.766 × 10-3 ), compared with 3.024 × 10-3 (95% CI 0.329-10.098 × 10-3 ) for under fives who did not seek health care. Quality of life years loss per episode was less for older children and adults, estimated as 1.950 × 10-3 (0.185-9.578 × 10-3 ) and 1.543 × 10-3 (0.136-6.406 × 10-3 ) for those who seek or do not seek health care, respectively. | en_US |
dc.language.iso | en | en_US |
dc.subject | EQ-5D | en_US |
dc.subject | cost-effectiveness | en_US |
dc.subject | health-related quality of life | en_US |
dc.subject | human respiratory syncytial virus | en_US |
dc.subject | quality-adjusted life years | en_US |
dc.subject | respiratory disease | en_US |
dc.title | Estimates for quality of life loss due to Respiratory Syncytial Virus. | en_US |
dc.type | Article | en_US |
dc.identifier.journal | Influenza Other Respir Viruses 2020; 14(1):19-27 | en_US |
dc.source.journaltitle | Influenza and other respiratory viruses |